Liberty One Investment Management LLC increased its position in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 580.8% in the 1st quarter, according to its most recent filing with the SEC. The fund owned 56,155 shares of the healthcare conglomerate's stock after purchasing an additional 47,907 shares during the period. UnitedHealth Group accounts for about 3.0% of Liberty One Investment Management LLC's holdings, making the stock its 13th biggest holding. Liberty One Investment Management LLC's holdings in UnitedHealth Group were worth $29,411,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds have also made changes to their positions in UNH. Marshall & Sterling Wealth Advisors Inc. purchased a new stake in UnitedHealth Group during the 4th quarter valued at approximately $26,000. Hurley Capital LLC purchased a new stake in UnitedHealth Group in the 4th quarter valued at approximately $28,000. Aster Capital Management DIFC Ltd purchased a new position in shares of UnitedHealth Group in the 4th quarter worth $30,000. IAG Wealth Partners LLC acquired a new stake in UnitedHealth Group in the 1st quarter valued at $42,000. Finally, Kapitalo Investimentos Ltda acquired a new stake in shares of UnitedHealth Group during the fourth quarter valued at about $41,000. 87.86% of the stock is owned by hedge funds and other institutional investors.
Insider Activity at UnitedHealth Group
In other UnitedHealth Group news, Director Kristen Gil purchased 3,700 shares of the company's stock in a transaction that occurred on Thursday, May 15th. The stock was acquired at an average cost of $271.17 per share, with a total value of $1,003,329.00. Following the completion of the purchase, the director directly owned 3,818 shares in the company, valued at approximately $1,035,327.06. This represents a 3,135.59% increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Stephen J. Hemsley acquired 86,700 shares of the business's stock in a transaction that occurred on Friday, May 16th. The stock was acquired at an average price of $288.57 per share, for a total transaction of $25,019,019.00. Following the completion of the acquisition, the chief executive officer directly owned 679,493 shares of the company's stock, valued at $196,081,295.01. This trade represents a 14.63% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders acquired 109,408 shares of company stock valued at $31,607,768 in the last three months. 0.28% of the stock is currently owned by corporate insiders.
Analysts Set New Price Targets
UNH has been the subject of a number of research reports. Deutsche Bank Aktiengesellschaft decreased their price target on UnitedHealth Group from $521.00 to $362.00 and set a "buy" rating for the company in a research note on Wednesday, May 14th. Truist Financial reaffirmed a "buy" rating and set a $360.00 target price (down previously from $580.00) on shares of UnitedHealth Group in a research note on Monday, May 19th. Barclays reduced their price objective on shares of UnitedHealth Group from $350.00 to $337.00 and set an "overweight" rating for the company in a research report on Wednesday. JPMorgan Chase & Co. lifted their price target on shares of UnitedHealth Group from $405.00 to $418.00 and gave the stock an "overweight" rating in a research report on Friday, June 20th. Finally, TD Cowen lowered UnitedHealth Group from a "buy" rating to a "hold" rating and set a $308.00 price objective for the company. in a research note on Monday, May 19th. One analyst has rated the stock with a sell rating, nine have given a hold rating and sixteen have issued a buy rating to the company's stock. According to data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average price target of $415.00.
View Our Latest Research Report on UNH
UnitedHealth Group Stock Performance
Shares of UnitedHealth Group stock traded down $3.76 during midday trading on Thursday, hitting $299.15. The company had a trading volume of 11,171,466 shares, compared to its average volume of 7,644,037. The business's 50 day simple moving average is $318.44 and its two-hundred day simple moving average is $443.71. The stock has a market cap of $271.37 billion, a PE ratio of 12.53, a P/E/G ratio of 1.47 and a beta of 0.45. The company has a debt-to-equity ratio of 0.71, a current ratio of 0.85 and a quick ratio of 0.85. UnitedHealth Group Incorporated has a 1-year low of $248.88 and a 1-year high of $630.73.
UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). UnitedHealth Group had a return on equity of 26.29% and a net margin of 5.39%. The business had revenue of $109.58 billion for the quarter, compared to analyst estimates of $111.56 billion. During the same quarter in the prior year, the firm earned $6.91 EPS. As a group, equities analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.
UnitedHealth Group Increases Dividend
The company also recently declared a quarterly dividend, which was paid on Tuesday, June 24th. Investors of record on Monday, June 16th were issued a dividend of $2.21 per share. This is an increase from UnitedHealth Group's previous quarterly dividend of $2.10. This represents a $8.84 annualized dividend and a yield of 2.96%. The ex-dividend date was Monday, June 16th. UnitedHealth Group's dividend payout ratio (DPR) is currently 37.02%.
About UnitedHealth Group
(
Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Further Reading

Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.
Get This Free Report